Showing results (1-10 of 407) with videos related to
Sort By:
Pageof 41
Infectious Disease Clinics of North America|February 15, 2011
Building a successful infection prevention program: key components, processes, and economicsEvelyn Cook, Dror Marchaim, Keith S KayeAdvances in Experimental Medicine and Biology|August 1, 2019
Use of Colistin in Critically Ill PatientsDror Marchaim, Donald Kaye, Keith S KayeInfection Control and Hospital Epidemiology|May 22, 2010
Suction regulators: a potential vector for hospital-acquired pathogensKeith S Kaye, Dror Marchaim, Chester Smialowicz, et al.Pharmacotherapy|September 20, 2011
Revisiting "older" antimicrobials in the era of multidrug resistanceJason M Pogue, Dror Marchaim, Donald Kaye, et al.American Journal of Infection Control|August 23, 2015
Epidemiology of CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli among older adultsSachi Matsubayashi, Keith S Kaye, Sameen Farooq, et al.Obstetrics and Gynecology|November 22, 2012
Fluconazole-resistant Candida albicans vulvovaginitisDror Marchaim, Leslie Lemanek, Suchitha Bheemreddy, et al.American Journal of Infection Control|April 30, 2014
Extended-spectrum β-lactamase-producing Escherichia coli isolation among older adults: epidemiology and outcomesSameen Farooq, Kayoko Hayakawa, Dror Marchaim, et al.Infectious Disease Clinics of North America|August 13, 2016
Building a Successful Infection Prevention Program: Key Components, Processes, and EconomicsSorabh Dhar, Evelyn Cook, Mary Oden, et al.American Journal of Infection Control|March 4, 2014
Effectiveness and cost of implementing an active surveillance screening policy for Acinetobacter baumannii: a Monte Carlo simulation modelJoseph R Coyle, Keith S Kaye, Thomas Taylor, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2011
Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health systemJason M Pogue, Jiha Lee, Dror Marchaim, et al.Pageof 41